XXXX after cadaveric and living donor liver transplantation.

@entity1 @entity410 @entity63 @entity75 @entity16 @entity205 @entity1140
Problems related to the central nervous system have a major impact on survival and quality of life. The aim of this retrospective study was to evaluate the incidence of @entity16 after liver transplantation (LT), including both cadaveric and living donor liver transplantation. Between April 2001 and March 2004 174 @entity1 (120 cadaveric liver transplantations, 54 living donor transplantations) were admitted to our intensive care after liver transplantation. Of the transplanted @entity1 24.7% developed @entity16 . These @entity1 ' stay in the intensive care (14.2 +/- 17.2 days) was much longer than that of all admitted @entity1 (8.4 +/- 10.5 days, p < 0.05). The most common @entity16 were @entity75 (72.1%) and @entity410 (11.6 %). The incidence of @entity16 in living donor liver transplanted @entity1 was significantly lower than in cadaveric transplantation @entity1 (20.4% vs 26.7 %). The @entity63 time in living donor transplanted @entity1 was significantly shorter in comparison with cadaveric transplanted @entity1 (215 +/- 119.3 vs. 383.7 +/- 214.7). The survival rate after liver transplantation of @entity1 with @entity16 was lower than that of @entity1 without, but not significantly different (79.1 % vs. 82.4%, p > 0.05). The incidence of @entity16 was found to be similar between the @entity1 treated with @entity205 (25%) and @entity1140 (23.8 %) in this study. In conclusion, there was a high incidence of @entity16 after LT, prolonging the @entity1 ' stay in intensive care significantly. The major neurological manifestation in our @entity1 was @entity75 followed by @entity410 . Living donor liver transplantation was associated with a significantly lower incidence of @entity16 compared with @entity1 who had received a cadaveric graft. This might be due to the good quality of the organ and the much shorter @entity63 time of the graft when the donor was alive.
